Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$913M |
| 2 |
Meta Platforms (Facebook)
META
|
+$659M |
| 3 |
Caterpillar
CAT
|
+$450M |
| 4 |
PayPal
PYPL
|
+$435M |
| 5 |
Becton Dickinson
BDX
|
+$348M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$860M |
| 2 |
Humana
HUM
|
+$581M |
| 3 |
Goldman Sachs
GS
|
+$372M |
| 4 |
Boston Scientific
BSX
|
+$345M |
| 5 |
Walmart Inc
WMT
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.36% |
| 2 | Healthcare | 2.87% |
| 3 | Financials | 2.57% |
| 4 | Consumer Discretionary | 2.23% |
| 5 | Industrials | 2.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
7101
PUT
Bionano Genomics
BNGO
$13.9M
| $822K | ﹤0.01% |
938
-152
| -14% | -$191K |
|
7102
Nuveen ESG Dividend ETF
NUDV
$51.1M
| $822K | ﹤0.01% |
+34,302
| New | +$811K |
|
7103
CALL
Purple Innovation
PRPL
$25.2M
| $821K | ﹤0.01% |
6,860
-1,368
| -17% | -$150K |
|
|
RNAM
7104
PUT
DELISTED
Avidity Biosciences
RNAM
| $821K | ﹤0.01% |
+37,000
| New | +$552K |
|
7105
CALL
TPG
TPG
$8.35B
| $821K | ﹤0.01% |
29,500
-144,800
| -83% | -$4.56M |
|
|
ISZE
7106
DELISTED
iShares MSCI Intl Size Factor ETF
ISZE
| $821K | ﹤0.01% |
34,175
+15,693
| +85% | +$362K |
|
|
NEX
7107
CALL
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $821K | ﹤0.01% |
88,800
+11,000
| +14% | +$108K |
|
7108
PUT
Cognex
CGNX
$10.7B
| $820K | ﹤0.01% |
17,400
-53,400
| -75% | -$2.5M |
|
|
BASE
7109
CALL
DELISTED
Couchbase
BASE
| $819K | ﹤0.01% |
61,800
-31,300
| -34% | -$405K |
|
7110
CALL
PLAYSTUDIOS Inc
MYPS
$61.3M
| $819K | ﹤0.01% |
211,200
+61,500
| +41% | +$247K |
|
|
DOC
7111
CALL
DELISTED
PHYSICIANS REALTY TRUST
DOC
| $819K | ﹤0.01% |
56,600
-5,500
| -9% | -$79.9K |
|
7112
ALPS REIT Dividend Dogs ETF
RDOG
$11.1M
| $819K | ﹤0.01% |
21,669
+9,194
| +74% | +$359K |
|
|
RPT
7113
Rithm Property Trust
RPT
$101M
| $818K | ﹤0.01% |
+18,812
| New | +$878K |
|
|
LOVE
7114
LoveSac
LOVE
$250M
| $818K | ﹤0.01% |
37,179
-153,197
| -80% | -$3.43M |
|
7115
CALL
VanEck Morningstar Wide Moat ETF
MOAT
$12.2B
| $818K | ﹤0.01% |
+12,600
| New | +$817K |
|
7116
Atlanta Braves Holdings Series A
BATRA
$3.62B
| $818K | ﹤0.01% |
25,028
-6,070
| -20% | -$192K |
|
7117
PUT
Biohaven
BHVN
$2.05B
| $818K | ﹤0.01% |
+58,900
| New | +$832K |
|
7118
Innovator US Equity Buffer ETF April
BAPR
$413M
| $817K | ﹤0.01% |
26,337
+12,069
| +85% | +$371K |
|
7119
ALPS Medical Breakthroughs ETF
SBIO
$228M
| $817K | ﹤0.01% |
26,886
+17,270
| +180% | +$520K |
|
7120
CALL
Schwab Emerging Markets Equity ETF
SCHE
$12.7B
| $817K | ﹤0.01% |
34,500
-26,300
| -43% | -$612K |
|
7121
iShares US Industrials ETF
IYJ
$1.94B
| $816K | ﹤0.01% |
8,462
-12,406
| -59% | -$1.17M |
|
7122
CorMedix
CRMD
$637M
| $816K | ﹤0.01% |
193,369
+133,561
| +223% | +$473K |
|
|
MGI
7123
DELISTED
MoneyGram International, Inc. New
MGI
| $816K | ﹤0.01% |
+74,910
| New | +$802K |
|
|
CGC
7124
Canopy Growth
CGC
$418M
| $816K | ﹤0.01% |
35,312
+20,403
| +137% | +$629K |
|
7125
WisdomTree US LargeCap Fund
EPS
$1.66B
| $815K | ﹤0.01% |
+19,609
| New | +$816K |
|
Similar funds
Ken Griffin's Q4 2022 Portfolio in Review
As of Q4 2022, Ken Griffin held 16,128 positions worth $428B, down 2.4% from $439B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin withdrew a net $22.3B in Q4 2022, closing 1,312 positions and reducing 5,802 holdings. Its most notable exit was Twitter, Inc., an estimated $297M position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.4% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ken Griffin opened a new position in Denbury Inc. worth $107M.
- Ken Griffin's largest Q4 2022 buy was Denbury Inc.: 1,228,903 shares worth $107M.
- Ken Griffin added most to Tesla in Q4 2022, an estimated $913M increase.
- Ken Griffin's biggest Q4 2022 reduction was Amazon, cutting an estimated $860M.
- Ken Griffin fully exited Twitter, Inc. in Q4 2022, selling an estimated $297M.
- Ken Griffin's ten largest holdings make up 28% of its $428B portfolio in Q4 2022.
- Ken Griffin opened 3,614 new positions and closed 1,312 in Q4 2022.
- Ken Griffin's portfolio value fell 2.4% quarter-over-quarter to $428B.
Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.